Literature DB >> 4073671

Immunocompetent cells in bronchoalveolar lavage reflect the cell populations in transbronchial biopsies in pulmonary sarcoidosis.

D A Campbell, L W Poulter, R M du Bois.   

Abstract

The purpose of this study was to examine the relationship between the inflammatory cells seen in transbronchial lung biopsy samples (TBB) and the bronchoalveolar lavage fluid (BAL) taken from patients with pulmonary sarcoidosis. Monoclonal antibodies and histochemical methods were used to identify mononuclear inflammatory cells in cryostat tissue sections and to compare these with cell populations in BAL-derived cytospin preparations. The subsets of lymphocytes identified in BAL accurately reflected the type and proportion of subsets present in the TBB. Although the ratio of T4+:T8+ lymphocytes was variable from patient to patient, concordance between BAL and TBB specimens was found in each subject. In the BAL, a high proportion of T lymphocytes expressed class II MHC antigen (HLADR+). Monoclonal antibodies were also used to identify subpopulations of macrophages and dendritic cells in the BAL and tissue samples. Macrophage subsets defined by phenotypic differences were found in both cases. Although no clear quantitative correlation could be established, a qualitative concordance was revealed. These results suggest that analysis of BAL samples accurately reflects the heterogeneity of the mononuclear inflammatory cell infiltrate in tissue biopsy samples in sarcoidosis. However, the spatial relationships between subpopulations of cells identified by immunohistologic analysis in tissue sections offers insights into the pathogenetic mechanisms involved that are not revealed by analysis of cytospin preparations from BAL.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4073671     DOI: 10.1164/arrd.1985.132.6.1300

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  16 in total

1.  Inhaled corticosteroids in pulmonary sarcoidosis.

Authors:  M A Spiteri
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

2.  Subpopulations of T cells in lung biopsies from patients with pigeon breeder's disease.

Authors:  R Barrios; M Selman; R Franco; R Chapela; J S López; T I Fortoul
Journal:  Lung       Date:  1987       Impact factor: 2.584

Review 3.  Immune aspects of sarcoidosis.

Authors:  L W Poulter
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

4.  Immunological features of lung lavage cells from patients with primary biliary cirrhosis may reflect those seen in pulmonary sarcoidosis.

Authors:  M A Spiteri; M Johnson; O Epstein; S Sherlock; S W Clarke; L W Poulter
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

5.  Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis.

Authors:  M A Spiteri; S W Clarke; L W Poulter
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

6.  The distribution of phenotypically distinct macrophage subsets in the lungs of patients with cryptogenic fibrosing alveolitis.

Authors:  B Noble; R M Du Bois; L W Poulter
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

7.  Phenotypic analysis of alveolar macrophages in normal subjects and in patients with interstitial lung disease.

Authors:  D A Campbell; L W Poulter; R M Du Bois
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

8.  Localization of T cells, macrophages and dendritic cells in rat respiratory tract tissue: implications for immune function studies.

Authors:  P G Holt; M A Schon-Hegrad
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

Review 9.  The many uses of bronchoalveolar lavage.

Authors:  H M Morrison; R A Stockley
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-25

10.  The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis.

Authors:  D A Campbell; R M du Bois; R G Butcher; L W Poulter
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.